Michael D. West - 11 Sep 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Chief Executive Officer, Director
Signature
/s/Michael D. West
Issuer symbol
SER
Transactions as of
11 Sep 2021
Net transactions value
-$1,078
Form type
4
Filing time
21 Sep 2021, 21:14:28 UTC
Previous filing
15 Jun 2021
Next filing
14 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock, $0.0001 par value Options Exercise $0 +3,125 +9.1% $0.000000 37,608 11 Sep 2021 Direct
transaction AGE Common Stock, $0.0001 par value Tax liability $1,078 -1,081 -2.9% $0.9975 36,527 11 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Restricted Stock Units Options Exercise $0 -3,125 -14% $0.000000 18,750 11 Sep 2021 Common Stock 3,125 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F2 Restricted Stock Units vested on September 11, 2021.